Helicobacter

Article	Citations
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o	84
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis	69
Issue Information	59
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals	49
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis	49
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis	48
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs	47
Expansion of cagA Copy Number in Helicobacter pylori During Co‐Infection in a Mouse Model	43
Second‐ and Third‐Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013–2023 of the European Registry on	43
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China	43
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection	41
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer	40
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting	40
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐ EuReg	39
	38
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up	36
Issue Information	31
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia	30
Droplet Digital PCR ‐Based Detection of Clarithromycin Resistance on Rapid Urease Test Samples Predicts	30
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”	28
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines	25
Roles of Gastric Non‐Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review	24
Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicro	22
EUROHELICAN —Accelerating Gastric Cancer Reduction Through Helicobacter pylori	22
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial	22

Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship	22
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin	21
Helicobacter pylori , Inflammation, and Long‐Term Outcome in Patients With Acute Myocardial Infarction: A Prospective Cohort Study	21
Exosome‐Based Detection of Helicobacter pylori Infection and Clarithromycin Resistance in Children	21
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis	21
Efficacy and Safety of Levofloxacin‐ Versus Moxifloxacin‐Based Nitazoxanide Quadruple Therapy as Second‐Line Treatment for Helicobacter pylori	21
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study	21
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction	20
Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase <	20
Perspectives from recent advances of Helicobacter pylori vaccines research	20
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis	20
Assessing the Capabilities of Novel Open‐Source Artificial Intelligence—DeepSeek in Helicobacter pylori‐Related Queries	19
Helicobacter pylori and Impaired Early Childhood Development—Evidence From a Birth Cohort Study From Ghana and Côte d'Ivoire	19
	19
Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Er	18
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia	18
Characterization of Fecal Microbial Communities in Patients With Type 2 Diabetes Mellitus Combined With Helicobacter pylori Infection	17
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial	17
Host Genetic Variants Associated With Helicobacter pylori Infection: A Meta‐Analysis Combined With	17
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori‐Infected Peptic Ulcer Children in Vietnam	16
Development and Evaluation of a Multi‐Epitope Vaccine Based on P22 Virus‐Like Particles Targeting Helicobacter pylori	16
Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis	16
Efficacy and Safety of Keverprazan–Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori	16
Influences ofHelicobacter pyloriinfection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development	16
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis	16
Inquiry about methodology used to isolate multiple Helicobacter pylori strains from the same patient	15
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia	15
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European stu	15
Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial	15
Boosting the Anti‐ Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Doc	14
An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Mod	14
Molecular detection of Helicobacter pylori and its genotypic antimicrobial resistance patterns in dyspeptic Mozambican patients	14
The expression and function of theB7family inHelicobacter pyloriinfection and gastric carcinogenesis process	14
The Gastric Microbiota Invade the Lamina Propria in Helicobacter pylori ‐Associated Gastritis and Precancer	13
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow‐up of 51 months	13
Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious	13
Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy	13
Issue Information	13
The Association of a Positive Fecal Immunochemical Test With the Risk of Gastroesophageal Cancer: An Age‐Sex‐ H. Pylori Exposure Matched Cohort Study and	13
Effect of Lactobacillus gasseri BIO 6369 and Lacticaseibacillus rhamnosus <	13
Changes of Helicobacter pylori Infection Status and Risk of Precancerous Lesions: A Prospective Cohort Study in Chinese Population	13
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes	12
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori	12
	12
Antibiotic Combinations in Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta‐Analysis	12
Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori	12
Letter to the Editor: Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential	12
Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis	12
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis	11
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice	11

The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response	11
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis	11
Reevaluating the Adverse Events With the Same‐Dosage Regimen in Hemodialysis Patients Undergoing Helicobacter pylori Eradication	11
Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for	11
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target	11
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug	11
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori	11
Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program	11
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor	11
Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More E	10
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review	10
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans	10
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori	10
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High‐Dosage L. reuteri in H. pylori	10
Issue Information	10
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries	10
Optimizing Duration and Dosing Frequency of Vonoprazan–Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial	10
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence	10
Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation	9
Optimizing Benefits‐Harms of H. pylori Screen‐and‐Treat Programs Tailored to the Regional Settings	9
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023	9
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence	9
Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?	9
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development	9
Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases	9
Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals	9
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review	9
Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study	9
	9
Helicobacter pyloriCagA Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells	9
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review	9
Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐ CREATE St	9
Intravenous metronidazole‐, levofloxacin‐containing triple therapy for treating patients with Helicobacter pylori‐related active peptic ulcer complications: A pilot study	8
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice	8
Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis	8
Knowledge and Practices of Helicobacter pylori Infection Management Among Physicians in Gansu Province, China: A Cross‐Sectional Study	8
Tracking the Helicobacter pylori Epidemic in Adults and Children in China	8
	8
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea	8
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis	8
Immunoinformatics‐Based Designing of Novel and Potent Multi‐Epitope PSA D15 and Cag11 Immunogens for Helicobacter pylori Immunodiagnostic Assay Development	8
In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori	8
Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of Helicobacter pylori Infection: A Randomized, Open‐Label, Noninferiority	8
Drug Repurposing Identifies Natamycin and Avacopan as Urease‐Targeted Therapeutic Candidates Against Helicobacter pylori	8
Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp‐EuReg): Results of a Nationwide Survey	8
Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review	8
New insight on the role of Helicobacter pylori cagA in the expression of cell surface antigens with important biological functions in gastric carcinogenesis	8
Artificial Intelligence‐Generated Patient Education Materials for Helicobacter pylori Infection: A Comparative Analysis	8
Gastric mucosal swab as an alternative to biopsy for Helicobacter pylori detection	8
Quantitative PCR of string‐test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptib	8
	7
Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta‐analysis	7
Impact of mixed‐infection rate of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains on the success rate of clarithromycin‐based eradication treatment	7
Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study	7
Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double‐blind, placebo‐controlled trial	7
Network meta‐analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori	7
Issue Information	7
First‐Line Therapy for Helicobacter pylori in Slovenia: Data From 2013 to 2023 of the European Registry on H. pylori Management	7
Influence of oipA Phase Variation on Virulence Phenotypes Related to Type IV Secretion System in Helicobacter pylori	7
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System	7
Candidate Antigens and the Development of Helicobacter pylori Vaccines	7
Helicobacter pylori virulence genotypes in Bogotá River and wastewater treatment plants in Colombia	7
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota	6
	6
Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study	6
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?	6
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis	6
Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential	6
Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial	6
	6
Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review	6
A case of neonatal thrombocytopenia due to maternal Helicobacter pylori‐associated immune thrombocytopenia	6
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China	6
Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A Nationa	6
Incidence of Gastric Cancer and Neuroendocrine Tumors in Autoimmune Gastritis: A Systematic Review and Meta‐Analysis of Follow‐Up Studies	6
H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: A cross‐sectional study	6
REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020	6
Issue Information	6
Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head‐To‐Head Comparison of Lateral Flow and Enzyme‐Linked Immunosorbent Assays	6
Helicobacter pylori Eradication Primary Care First‐Line Prescriptions: Data From 200,000 Patients in a Real‐World Coho	6

Issue Information	5
Helicobacter pylori regulated microRNA map of human gastric cells	5
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy	5
Two novel sequence types of Helicobacter pylori strains: The first report from Turkey	5
Treatment failure is a key factor in the development of Helicobacter pylori resistance	5
Helicobacter pyloriresults in lysis and death after exposure to water	5
Galangin Alleviates Helicobacter pylori Gastritis Through TLR2 Inhibition and Modulation of the	5
Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article	5
	5
	5
Gastric Cancer Screening: Intention to Adhere and Patients' Perspective	5
Combatting Helicobacter pylori: A Focus on Nanomaterials	5
Helicobacter pylori Pathogenic Factors and Their Interactions With the Gastric Microbiome	5
Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?	5
The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection	5
Antimicrobial‐resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018–2020	4
Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review	4
Correction to “Long‐Term Effects of Fecal Microbiota Transplantation on Gut Microbiota After Helicobacter pylori Eradication With Bismuth Quadruple Thera	4
Helicobacter pylori and Colorectal Cancer: Meeting Sir Austin Bradford Hill's Causality Criteria	4
Correction to Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review	4
	4
Helicobacter pylori induces urease subunit B‐specific CD8+ T cell responses in infected individuals via cytosolic pathway of cross‐presentation	4
Vonoprazan‐amoxicillin dual therapy versus bismuth‐containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis	4
Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis	4
YouTube as a source of information on Helicobacter pylori: Content and quality analysis	4
Helicobacter pylori Management in Africa: A Survey of Diagnostic, Treatment, and Related Resources	4
Incidence of gastrointestinal malignancies increases in persons received eradication therapy for Helicobacter pylori: A cohort study	4
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran	4
	4
The Optimal Age of Helicobacter pylori Screen‐and‐Treat for Gastric Cancer Prevention in the United States	4
Issue Information	4
A comprehensive evaluation of an animal model for Helicobacter pylori‐associated stomach cancer: Fact and controversy	4
Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection	4
	4
Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infecti	4
Overall and Stratified Accuracies of H. pylori Serology Testing: A Multicenter Study of 8497 Screening‐Naïve Adults	4
Long‐term effects of fecal microbiota transplantation on gut microbiota after Helicobacter pylori eradication with bismuth quadruple therapy: A randomize	4
Efficacy of Bismuth Therapy in Eradicating Helicobacter pylori in Children—Data From the RENIHp Registry	4
Correction to “Letter to the Editor: ‘Parietal Cell Antibody Levels Among Chronic Gastritis Patients in a Country With Low Helicobacter pylori Infection:	3
Helicobacter pylori Eradication in Older Individuals: A Systematic Review and Meta‐Analysis	3
Vonoprazan–Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial	3
A Three‐Way Comparison of Nodular Lesions in H. pylori ‐Induced Gastritis, Non‐ Helicobacter pylori Helicobacter	3
Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection	3
Lipidome Characterization Reveals Alterations of Fatty Acid Metabolism in Helicobacter pylori Infection	3
Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial	3
Prevalence of multidrug‐resistant Campylobacter species in wastewater effluents: A menace of environmental and public health concern	3
	3
Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real‐World Evidence Study	3
Transcriptomic remodeling of gastric cells by Helicobacter pylori outer membrane vesicles	3
Research trends on the relationship between Helicobacter pylori and microbiota: A bibliometric analysis	3
Helicobacter pylori ‐Associated Extranodal Marginal Zone Lymphoma of Mucosa‐Associated Tissue in Children: A Multicenter Case Series	3
Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, Italy	3
Helicobacter pylori Eradication Is Associated With a Reduced Risk of Metachronous Gastric Neoplasia by Restoring Immune Function in the Gastric Mucosa	3
TikTok and Bilibili as sources of information on Helicobacter pylori in China: A content and quality analysis	3
Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predomi	3
Antibiotic resistance, heteroresistance, and eradication success ofHelicobacter pyloriinfection in children	3
Helicobacter 30 Years On: A Message From the Editor, Emeritus	3
Artificial Intelligence in Endoscopy for Predicting Helicobacter pylori Infection: A Systematic Review and Meta‐Analysis	3
Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Tr	3
States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis	3
Achieving Helicobacter pylori eradication in the primary treatment requires a deep integration of personalization and standardization	3
The association between Helicobacter pylori and gastrointestinal disorders during pregnancy: A Multicenter retrospective study	3
Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial	3
The nonadherence and risk factors of eradication failure by sequential therapy as first‐line anti‐Helicobacter pylori treatment in real‐world clinical practice	3
Prevalence of Autoimmune Gastritis Worldwide: A Systematic Review and Meta‐Analysis	3
Vonoprazan‐based therapies versus PPI‐based therapies in patients with H. pylori infection: Systematic review and meta‐analyses of randomized controlled trials	3
Cover Image	3
14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open‐label randomized noninferiority contro	3